Table 3.
The correlations of miR-215-3p with clinicopathological features of patients with gastric cancer
| Characteristics | Patients(n) | miR-215-3p expression |
P values | |
|---|---|---|---|---|
| Low expression (n = 17) | High expression (n = 31) | |||
| Age (years) | ||||
| ≤60 | 32 | 11 | 21 | 0.831 |
| >60 | 16 | 6 | 10 | |
| Tumor size (cm) | ||||
| ≤5 | 16 | 4 | 12 | 0.037* |
| >5 | 32 | 13 | 9 | |
| Gender | ||||
| Male | 31 | 13 | 18 | 0.202 |
| Female | 17 | 4 | 13 | |
| TNM stage | ||||
| I – II | 27 | 6 | 21 | 0.030* |
| III–IV | 21 | 11 | 10 | |
| Tumor differentiation | ||||
| Well + moderate | 29 | 4 | 25 | <0.001*** |
| Poor | 19 | 13 | 6 | |
| Lymph node metastasis | ||||
| Absent | 28 | 7 | 21 | 0.074 |
| Present | 20 | 10 | 10 | |
| Distant metastasis | ||||
| Absent | 21 | 6 | 15 | 0.382 |
| Present | 27 | 11 | 16 | |
*P < 0.05, and *** P < 0.001.